Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer. (2018)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci125184
PubMed Identifier: 30382943
Publication URI: http://europepmc.org/abstract/MED/30382943
Type: Journal Article/Review
Volume: 128
Parent Publication: The Journal of clinical investigation
Issue: 11
ISSN: 0021-9738